EUVIMEDEUVIMED entdecken
Open Access

Prevalence of Neutralizing Antibodies to AAV2 and AAV9 in Individuals with Niemann-Pick Disease, Type C1

Avani V Mylvara iD, Cristin D Davidson iD, Derek Alexander iD, Charles P Venditti iD, Forbes D Porter iD

Human Gene Therapy · 2025

DOI: 10.1089/hum.2024.233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Gene Therapy, 2025. Verfasst von Avani V Mylvara und 4 weiteren Autor:innen. Beteiligte Einrichtung: Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Human Health and Servic…. Hauptthemen laut MEDLINE: Dependovirus, Antibodies, Neutralizing, Niemann-Pick Disease, Type C, Antibodies, Viral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusAntibodies, NeutralizingNiemann-Pick Disease, Type CAntibodies, ViralHumansAdolescentChildGenetic TherapyGenetic VectorsChild, PreschoolMaleFemaleAdultInfantYoung AdultNiemann-Pick C1 Protein

Stichwörter der Autor:innen

AAV2AAV9Niemann-Pick disease type C1neurodegenerative diseaseneutralizing antibodiesseroprevalence

Substanzen

Antibodies, NeutralizingAntibodies, ViralNiemann-Pick C1 Protein

Autor:innen und Institutionen

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Human Health and Services, Bethesda, Maryland, USA.
  • National Human Genome Research Institute, National Institutes of Health, Department of Human Health and Services, Bethesda, Maryland, USA.

ORCID-Profile: Avani V Mylvara, Cristin D Davidson, Derek Alexander, Charles P Venditti, Forbes D Porter

Förderung

  • Intramural NIH HHS

Zitieren

APA

Mylvara, A. V., Davidson, C. D., Alexander, D., Venditti, C. P., & Porter, F. D. (2025). Prevalence of Neutralizing Antibodies to AAV2 and AAV9 in Individuals with Niemann-Pick Disease, Type C1. Human Gene Therapy. https://doi.org/10.1089/hum.2024.233

Vancouver

Mylvara AV, Davidson CD, Alexander D, Venditti CP, Porter FD. Prevalence of Neutralizing Antibodies to AAV2 and AAV9 in Individuals with Niemann-Pick Disease, Type C1. Human Gene Therapy. 2025. doi:10.1089/hum.2024.233

BibTeX
@article{Mylvara2025,
  author = {Mylvara, Avani V and Davidson, Cristin D and Alexander, Derek and Venditti, Charles P and Porter, Forbes D},
  title = {Prevalence of Neutralizing Antibodies to AAV2 and AAV9 in Individuals with Niemann-Pick Disease, Type C1},
  journal = {Human Gene Therapy},
  year = {2025},
  doi = {10.1089/hum.2024.233}
}
Kostenlos starten →